Literature DB >> 4364895

Inhibition of the multiplication of vesicular stomatitis and Newcastle disease virus by 2-deoxy-d-glucose.

C Scholtissek, R Rott, G Hau, G Kaluza.   

Abstract

The production of infectious vesicular stomatitis (VSV) and Newcastle disease virus can be completely inhibited by 2-deoxy-d-glucose in pyruvate-containing medium, if virus either grown in pyruvate-containing medium or dialyzed against phosphate-buffered saline is used for infection. Under these conditions, the synthesis of all VSV proteins is reduced. VSV RNA, which is synthesized at reduced rates, seems to be unstable. The effect is completely reversible. If virus grown in glucose-containing medium is used for infection, the production of both viruses is not significantly inhibited by 2-deoxy-d-glucose. Under these conditions the production of the VSV glycoprotein is specifically impaired, but does not lead to a marked reduction of the yield of infectious virus.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4364895      PMCID: PMC355437     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose.

Authors:  G Kaluza; C Scholtissek; R Rott
Journal:  J Gen Virol       Date:  1972-03       Impact factor: 3.891

2.  The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion.

Authors:  H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

3.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

4.  Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose.

Authors:  H D Klenk; C Scholtissek; R Rott
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

5.  Detection of an unstable RNA in chick fibroblasts after reduction of the UTP pool by glucosamine.

Authors:  C Scholtissek
Journal:  Eur J Biochem       Date:  1971-12

6.  Effect of temperature on the multiplication of an Influenza virus.

Authors:  C Scholtissek; R Rott
Journal:  J Gen Virol       Date:  1969-09       Impact factor: 3.891

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics.

Authors:  C Scholtissek; R Rott
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

9.  Synthesis in vitro of RNA complementary to parental viral RNA by RNA polymerase induced by influenza virus.

Authors:  C Scholtissek
Journal:  Biochim Biophys Acta       Date:  1969-04-22

10.  Hydrogen ion buffers for biological research.

Authors:  N E Good; G D Winget; W Winter; T N Connolly; S Izawa; R M Singh
Journal:  Biochemistry       Date:  1966-02       Impact factor: 3.162

View more
  10 in total

1.  Effect of 2-deoxy-D-glucose on Herpetomonas samuelpessoai.

Authors:  M M Bunn; T C Soares; J Angluster; W De Souza
Journal:  Z Parasitenkd       Date:  1977-07-29

2.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature.

Authors:  T J Schnitzer; C Dickson; R A Weiss
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

4.  Effects of 2-deoxyglucose, glucosamine, and mannose on cell fusion and the glycoproteins of herpes simplex virus.

Authors:  R W Knowles; S Person
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

5.  A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy D glucose in treating COVID-19.

Authors:  Prajakta Kulkarni; Sriram Padmanabhan
Journal:  Biotechnol Lett       Date:  2022-05-24       Impact factor: 2.716

6.  Inhibition of herpes simplex virus replication by methyl daunosamine.

Authors:  J G Spivack; W H Prusoff; T R Tritton
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  Biological and physical modifications of a murine oncornavirus by 2-deoxy-D-glucose.

Authors:  E V Prochownik; S Panem; W H Kirsten
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

8.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.

Authors:  R Leavitt; S Schlesinger; S Kornfeld
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Dissociation of the inhibitory effects of 2-deoxy-D-glucose on Vero cell growth and the replication of herpes simplex virus.

Authors:  J G Spivack; W H Prusoff; T R Tritton
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.

Authors:  Roger A Laine
Journal:  Glycobiology       Date:  2020-09-28       Impact factor: 4.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.